Documents
Application Sponsors
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Application Products
001 | CAPSULE; ORAL | 50MG | 0 | THALOMID | THALIDOMIDE |
002 | CAPSULE; ORAL | 100MG | 0 | THALOMID | THALIDOMIDE |
003 | CAPSULE; ORAL | 200MG | 0 | THALOMID | THALIDOMIDE |
FDA Submissions
TYPE 6; Type 6 - New Indication (no longer used) | ORIG | 1 | AP | 2006-05-25 | STANDARD |
Submissions Property Types
CDER Filings
CELGENE
cder:Array
(
[0] => Array
(
[ApplNo] => 21430
[companyName] => CELGENE
[docInserts] => ["",""]
[products] => [{"drugName":"THALOMID","activeIngredients":"THALIDOMIDE","strength":"50MG","dosageForm":"CAPSULE; ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"THALOMID","activeIngredients":"THALIDOMIDE","strength":"100MG","dosageForm":"CAPSULE; ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"THALOMID","activeIngredients":"THALIDOMIDE","strength":"200MG","dosageForm":"CAPSULE; ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"05\/25\/2006","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/021430lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"THALOMID","submission":"THALIDOMIDE","actionType":"50MG","submissionClassification":"CAPSULE; ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"THALOMID","submission":"THALIDOMIDE","actionType":"100MG","submissionClassification":"CAPSULE; ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"THALOMID","submission":"THALIDOMIDE","actionType":"200MG","submissionClassification":"CAPSULE; ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 2006-05-25
)
)